Casey Cunningham, MD is the Chief Scientific Officer of Santé Ventures. Dr. Cunningham received his fellowship training in oncology and hematology at the Harvard Medical School, where he subsequently served on the faculty for a number of years. In 1999, he became the Associate Director of the Mary Crowley Cancer Research Institute in Dallas, Tx. The MCMRI performs early phase clinical trials in oncology and Dr. Cunningham had a particular focus on gene and immune approaches. During his time at MCMRI, Casey also provided consulting services to biotech and pharma companies, advising them on early stage drug development. Dr. Cunningham joined Santé Ventures in 2008 as CSO but has also served in operating roles for several of the fund’s portfolio companies.
